The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    16:45 – 18:05
    Clinical Trial Designs and Regulatory Affairs

    Society Session: European Society of Oncology Pharmacy (ESOP)

    Chair: K. Meier (Germany)

    16:45
    ESOP-ESMO Drug shortage survey
    Speaker: M. Saar (Estonia)
    Display Presentation Details

    16:45
    ESOP-ESMO Drug shortage survey
    Speaker: G.J. Wiedemann (Germany)

    17:10
    EPIC project on oral chemotherapy
    Speaker: A. Eberl (Slovenia)
    Display Presentation Details

    17:25
    Pharmacovigilance in Slovenia
    Speaker: M. Sonc (Slovenia)
    Display Presentation Details

    17:35
    Cytotoxic contamination project
    Speaker: E. Korczowska (Poland)

    17:50
    Centres of exchange
    Speaker: C. Bardin (France)

    Klaus Meier Award

  • 27
    SUN
    11:30 – 12:30
    Clinical Trial Designs and Regulatory Affairs

    Special Session: How to Pay for New «Innovative» Anticancer Drugs?

    Chair: A. Astier (France)

    11:30
    A new way to pay high costly drugs: Payment for the performance
    Speaker: F. Megerlin (France)
    Display Presentation Details

    11:40
    The hunt for money: overpriced innovative cancer drugs in palliation & shortages of essential generic pharmaceuticals
    Speaker: G.J. Wiedemann (Germany)
    Display Presentation Details

    11:50
    Cost constraints in cancer treatment: What can nations do?
    Speaker: P. Cornes (United Kingdom)
    Display Presentation Details

    Discussion

  • 27
    SUN
    13:00 – 14:00
    Clinical Trial Designs and Regulatory Affairs

    Special Session: Values and Perspectives on the Role of Hospital Pharmacists’ Contribution to Clinical Research

    Chair: K. Meier (Germany)

    13:00
    Managing investigational medicinal products: The hospital pharmacist perspective
    Speaker: I. Madelaine (France)

    13:20
    How can sponsors facilitate quality of IMPs management at the hospital pharmacy
    Speaker: C. de Balincourt (Belgium)
    Display Presentation Details

    Discussion

  • 27
    SUN
    15:15 – 16:15
    Clinical Trial Designs and Regulatory Affairs

    Special Session: Oncology Pharmacy Aspects of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    Chair: K. Meier (Germany)

    Co-Chair: M. Daouphars (France)

    15:15
    Safe handling considerations in HIPEC
    Speaker: I. Netikova (Czech Republic)
    Display Presentation Details

    15:25
    Pharmacokinetic aspects of HIPEC
    Speaker: A. Paci (France)
    Display Presentation Details

    15:35
    State of the art of HIPEC clinical benefits
    Speaker: L. Petruzelka (Czech Republic)
    Display Presentation Details

    Discussion

  • 27
    SUN
    17:00 – 18:30
    Clinical Trial Designs and Regulatory Affairs

    Scientific Symposium: Therapeutic Drug Monitoring in Cancer

    Chair: A. Astier (France)

    Co-Chair: C. Csajka (Switzerland)

    17:00
    TDM of cytotoxic drugs
    Speaker: E. Chatelut (France)
    Display Presentation Details

    17:20
    TDM in specialised cancer populations
    Speaker: G. Veal (United Kingdom)
    Display Presentation Details

    17:40
    Is it useful to follow drug levels for targeted therapies?
    Speaker: C. Csajka (Switzerland)

    18:00
    TDM in pediatric oncology
    Speaker: A. Paci (France)
    Display Presentation Details

    Discussion & Roundup

Print all results list